Roche Company Profile

What is the competitive landscape for ROCHE

ROCHE has sixty-one approved drugs.

Summary for Roche

US Patents:	0
Tradenames:	49
Ingredients:	45
NDAs:	61

Drugs and US Patents for Roche

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roche	KLONOPIN RAPIDLY DISINTEGRATING	clonazepam	TABLET, ORALLY DISINTEGRATING;ORAL	020813-001	Dec 23, 1997		DISCN	Yes	No
Roche	LARODOPA	levodopa	CAPSULE;ORAL	016912-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Roche	LARODOPA	levodopa	TABLET;ORAL	016912-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Roche Palo	FEMSTAT	butoconazole nitrate	CREAM;VAGINAL	019215-001	Nov 25, 1985		DISCN	No	No
Roche	TRIMPEX	trimethoprim	TABLET;ORAL	017952-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Expired US Patents for Roche

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Roche	BONIVA	ibandronate sodium	INJECTABLE;INTRAVENOUS	021858-001	Jan 6, 2006	5,662,918
Roche	KLONOPIN RAPIDLY DISINTEGRATING	clonazepam	TABLET, ORALLY DISINTEGRATING;ORAL	020813-002	Dec 23, 1997	4,758,598
Roche	KYTRIL	granisetron hydrochloride	INJECTABLE;INJECTION	020239-003	Sep 17, 2004	4,886,808
Roche	HIVID	zalcitabine	TABLET;ORAL	020199-001	Jun 19, 1992	4,879,277
Roche	DEMADEX	torsemide	SOLUTION;INTRAVENOUS	020137-002	Aug 23, 1993	4,861,786

Paragraph IV (Patent) Challenges for ROCHE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	For Oral Suspension	200 mg/mL		2011-03-25
	Capsules	30 mg and 45 mg		2011-08-02
	Injection	0.1 mg/mL, 1 mL single dose vial		2007-03-08
	Injection	1 mg/mL, 4 mL multi-dose vials		2004-07-19
	Tablets	2.5 mg and 150 mg		2007-05-16
	Capsule	75 mg		2010-11-15
	Oral Suspension	6 mg/mL		2015-06-18
	Injection	1 mg/mL, 1 mL vials		2004-06-01
	Injection	1 mg/mL, 3 mL Vial		2007-08-31

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Roche
• Roche Palo